1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines

2. EXECUTIVE SUMMARY


3. PATIENT RECRUITMENT AND RETENTION IN CLINICAL TRIALS
3.1. Chapter Overview
3.2. Clinical Trials
3.2.1. Clinical Trial Phases
3.3. Patient Recruitment
3.3.1. The Patient Recruitment Process
3.3.2. Challenges Associated with Patient Recruitment
3.3.3. Strategies to Improve Patient Recruitment
3.3.4. Ethical Considerations
3.4. Outsourcing of Patient Recruitment
3.4.1. Patient Recruitment Services
3.5. Patient Retention
3.5.1. Patient Retention Services

4. PATIENT OUTREACH METHODS
4.1. Chapter Overview
4.2. Patient Outreach Methods
4.2.1. Traditional Media
4.2.1.1. Physician Referrals
4.2.1.2. Television
4.2.1.3. Radio
4.2.1.4. Print Media (Newspaper, Flyers, Brochures and Posters)
4.2.1.5. Direct Mail Campaigns
4.2.1.6. Cold Call / Call Center
4.2.1.7. Advantages and Limitations of Traditional Media
4.2.2. Emerging / Novel Methods
4.2.2.1. Social Media
4.2.2.1.1. Social Media Platforms Used in Patient Recruitment
4.2.2.1.1.1. Geo-Social Media
4.2.2.1.1.2. Social Networking Websites
4.2.2.1.2. Advantages and Limitations of Social Media
4.2.2.2. Mobile / Software Applications
4.2.2.3. Patient Networks
4.2.2.4. Patient Advocacy Groups
4.2.2.5. Electronic Medical Records (EMRs) / Electronic Health Records (EHRs) and Other Health Data
4.2.2.6. Promotion of Trials in Indication Specific Events for Patients
4.2.3. Best Practices / Recommendations for Patient Outreach

5. COMPETITIVE MARKET LANDSCAPE OF PATIENT RECRUITMENT AND RETENTION SERVICE PROVIDERS
5.1. Chapter Overview
5.2. Patient Recruitment and Retention Service Providers: Overall Market Landscape
5.2.1. Analysis by Year of Establishment
5.2.2. Analysis by Company Size
5.2.3. Analysis by Geography
5.2.4. Analysis by Patient Recruitment and Retention Services Offered
5.2.5. Analysis by Patient Outreach Methods
5.2.6. Analysis by Patient Recruitment Associated Services
5.2.7. Analysis by Patient Retention Methods
5.2.8. Analysis by Geographical Reach
5.2.9. Analysis by Therapeutic Expertise
5.2.10. Information on Payment Model, Recruitment Technology / Platform, and Regulatory Approval / Certification / Compliance Status

6. COMPANY COMPETITIVENESS ANALYSIS
6.1. Chapter Overview
6.2. Methodology
6.3. Assumptions and Key Parameters
6.4. Patient Recruitment and Retention Service Providers: Company Competitiveness Analysis
6.4.1. Small-Sized Companies
6.4.2. Mid-Sized Companies
6.4.3. Large Companies

7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Patient Recruitment Services Providers in North America
7.2.1. Acurian
7.2.1.1. Company Overview
7.2.1.2. Financial Information
7.2.1.3. Patient Recruitment and Retention Services
7.2.1.4. Recent Developments
7.2.1.5. Future Outlook
7.2.2. BBK Worldwide
7.2.2.1. Company Overview
7.2.2.2. Financial Information
7.2.2.3. Patient Recruitment and Patient Retention Services
7.2.2.4. Recent Developments
7.2.2.5. Future Outlook
7.2.3. Bright Pharmaceuticals Services
7.2.3.1. Company Overview
7.2.3.2. Patient Recruitment and Retention Services
7.2.3.3. Future Outlook
7.2.4. ClinEdge
7.2.4.1. Company Overview
7.2.4.2. Patient Recruitment and Retention Services
7.2.4.3. Recent Developments
7.2.4.4. Future Outlook
7.2.5. CSSi
7.2.5.1. Company Overview
7.2.5.2. Patient Recruitment and Retention services
7.2.5.3. Recent Development
7.2.5.4. Future Outlook
7.2.6. CTM
7.2.6.1. Company Overview
7.2.6.2. Patient Recruitment and Retention Services
7.2.6.3. Future Outlook
7.2.7. Integrated Clinical Trial Services (ICTS)
7.2.7.1. Company Overview
7.2.7.2. Patient Recruitment and Retention Services
7.2.7.3. Recent Developments
7.2.7.4. Future Outlook
7.2.8. MMG
7.2.8.1. Company Overview
7.2.8.2. Patient Recruitment and Retention Services
7.2.8.3. Future Outlook
7.2.9. WCCT Global
7.2.9.1. Company Overview
7.2.9.2. Financial Information
7.2.9.3. Patient Recruitment and Retention Services
7.2.9.4. Recent Development
7.2.9.5. Future Outlook
7.3. Patient Recruitment Services Providers in Europe
7.3.1. Antidote
7.3.1.1. Company Overview
7.3.1.2. Financial Information
7.3.1.3. Patient Recruitment and retention Services
7.3.1.4. Recent Developments
7.3.1.5. Future Outlook
7.3.2. FIDELIS RESEARCH
7.3.2.1. Company Overview
7.3.2.2. Financial Information
7.3.2.3. Patient Recruitment and Retention Services
7.3.2.4. Recent Developments
7.3.2.5. Future Outlook
7.3.3. Ignite Data
7.3.3.1. Company Overview
7.3.3.2. Financial Information
7.3.3.3. Patient Recruitment Services
7.3.3.4. Future Outlook
7.3.4. Polaris BioPharma Consulting
7.3.4.1. Company Overview
7.3.4.2. Patient Recruitment and Retention Services
7.3.4.3. Recent Developments
7.3.5. Raremark
7.3.5.1. Company Overview
7.3.5.2. Financial Information
7.3.5.3. Patient Recruitment and Retention Services
7.3.5.4. Recent Developments
7.3.5.5. Future Outlook
7.4. Patient Recruitment Services Providers in Asia Pacific
7.4.1. CROèe
7.4.1.1. Company Overview
7.4.1.2. Patient Recruitment and Retention Services
7.4.1.3. Recent Developments
7.4.1.4. Future Outlook
7.4.2. Gitzo Medical Technology
7.4.2.1. Company Overview
7.4.2.2. Patient Recruitment and Retention Services
7.4.2.3. Future Outlook
7.4.3. TrialWire
7.4.3.1. Company Overview
7.4.3.2. Patient Recruitment and Retention Services
7.4.3.3. Recent Developments
7.4.4. Pacific Grove
7.4.4.1. Company Overview
7.4.4.2. Patient Recruitment and Retention Services
7.4.4.3. Recent Developments
7.4.4.4. Future Outlook

8. PARTNERSHIPS AND COLLABORATIONS
8.1. Chapter Overview
8.2. Partnership Models
8.3. Patient Recruitment and Retention Services: List of Partnerships and Collaborations
8.3.1. Analysis by Year of Partnerships
8.3.2. Analysis by Type of Partnership
8.3.3. Analysis by Purpose of Agreement
8.3.4. Analysis by Therapeutic Area
8.3.5. Most Active Players: Analysis by Number of Partnerships
8.3.6. Geographical Analysis
8.3.6.1. Intercontinental and Intracontinental Agreements

9. RECENT TRENDS IN PATIENT RECRUITMENT AND RETENTION
9.1. Chapter Overview
9.1.1. Social Media-based Campaigning to Accelerate Patient Recruitment in Clinical Trials
9.1.2. Adoption of Mobile Technologies for Patient Recruitment and Retention
9.1.3. Use of EHR Data to Improve Patient Recruitment Rates
9.1.4. Other Real-World Data Sources to Help Overcome Patient Recruitment-Related Challenges
9.1.5. Growing Focus on Conducting Clinical Research in Emerging Markets

10. FUTURE GROWTH OPPORTUNITIES
10.1. Chapter Overview
10.1.1. Anticipated Increase in the Number of Global Clinical Trials
10.1.2. Growing Demand for Orphan Drugs and Personalized Medicine
10.1.3. Increased Offshoring of Clinical Development Operations to Emerging Regions
10.1.4. Availability of Service Providers Offering One-Stop-Solutions
10.1.5. Stringent Regulations and Complex Study Protocols Expected to Promote Outsourcing

11. MARKET SIZING AND OPPORTUNITY ANALYSIS
11.1. Chapter Overview
11.2. Forecast Methodology and Key Assumptions
11.3. Overall Patient Recruitment Services Market, 2019-2030
11.4. Patient Recruitment Services Market: Distribution by Therapeutic Area, 2019-2030
11.5. Patient Recruitment Services Market: Distribution by Steps in Patient Recruitment Process, 2019-2030
11.6. Patient Recruitment Services Market: Distribution by Phase of Development, 2019-2030
11.7. Patient Recruitment Services Market: Distribution by Geography, 2019-2030
11.7.1. Patient Recruitment Services Market: Market Attractiveness Analysis by Country, 2019-2030
11.7.2. Patient Recruitment Services Market in North America, 2019-2030
11.7.2.1. Patient Recruitment Services Market in the US: Distribution by Phase of Development, 2019-2030
11.7.2.2. Patient Recruitment Services Market in the US: Distribution by Therapeutic Area, 2019-2030
11.7.2.3. Patient Recruitment Services Market in Canada: Distribution by Phase of Development, 2019-2030
11.7.2.4. Patient Recruitment Services Market in Canada: Distribution by Therapeutic Area, 2019-2030
11.7.3. Patient Recruitment Services Market in EU5, 2019-2030
11.7.3.1. Patient Recruitment Services Market in Germany: Distribution by Phase of Development, 2019-2030
11.7.3.2. Patient Recruitment Services Market in Germany: Distribution by Therapeutic Area, 2019-2030
11.7.3.3. Patient Recruitment Services Market in France: Distribution by Phase of Development, 2019-2030
11.7.3.4. Patient Recruitment Services Market in France: Distribution by Therapeutic Area, 2019-2030
11.7.3.5. Patient Recruitment Services Market in the UK: Distribution by Phase of Development, 2019-2030
11.7.3.6. Patient Recruitment Services Market in the UK: Distribution by Therapeutic Area, 2019-2030
11.7.3.7. Patient Recruitment Services Market in Italy: Distribution by Phase of Development, 2019-2030
11.7.3.8. Patient Recruitment Services Market in Italy: Distribution by Therapeutic Area, 2019-2030
11.7.3.9. Patient Recruitment Services Market in Spain: Distribution by Phase of Development, 2019-2030
11.7.3.10. Patient Recruitment Services Market in Spain: Distribution by Therapeutic Area, 2019-2030
11.7.4. Patient Recruitment Services Market in Asia Pacific, 2019-2030
11.7.4.1. Patient Recruitment Services Market in Japan: Distribution by Phase of Development, 2019-2030
11.7.4.2. Patient Recruitment Services Market in Japan: Distribution by Therapeutic Area, 2019-2030
11.7.4.3. Patient Recruitment Services Market in South Korea: Distribution by Phase of Development, 2019-2030
11.7.4.4. Patient Recruitment Services Market in South Korea: Distribution by Therapeutic Area, 2019-2030
11.7.4.5. Patient Recruitment Services Market in Australia: Distribution by Phase of Development, 2019-2030
11.7.4.6. Patient Recruitment Services Market in Australia: Distribution by Therapeutic Area, 2019-2030
11.7.4.7. Patient Recruitment Services Market in China: Distribution by Phase of Development, 2019-2030
11.7.4.8. Patient Recruitment Services Market in China: Distribution by Therapeutic Area, 2019-2030
11.7.4.9. Patient Recruitment Services Market in India: Distribution by Phase of Development, 2019-2030
11.7.4.10. Patient Recruitment Services Market in India: Distribution by Therapeutic Area, 2019-2030
11.7.5. Patient Recruitment Services Market in Rest of the World, 2019-2030
11.7.5.1. Patient Recruitment Services Market in Rest of the World: Distribution by Phase of Development, 2019-2030
11.7.5.2. Patient Recruitment Services Market in Rest of the World: Distribution by Therapeutic Area, 2019-2030

12. CONCLUSION
12.1. Evolving Requirements Related to Patient Enrolment have Imposed a Significant Burden on Drug Developers, Causing Many to Outsource their Recruitment and Retention-related Processes
12.2. Several CROs Offer Patient Recruitment and Retention Services across the Globe; North America and Europe have Emerged as Key Hubs
12.3. Currently, a Variety of Outreach Methods are being used to Enroll Patient from Across Different Geographies and Therapeutic Areas
12.4. Innovation, Use of Real World Evidence and the Establishment of Strategic Alliances between Stakeholders are Anticipated to Act as Key Market Enablers
12.5. Driven by the Increasing Demand for Niche and Highly Specific Patient Populations in Clinical Trials, the Patient Recruitment Services Market is Anticipated to Witness Significant Growth in the Coming Decade

13. INTERVIEW TRANSCRIPTS
13.1. Chapter Overview
13.2. Link2Trials
13.2.1. Interview Transcript: Simon Klaasen, Co-founder and Managing Director
13.3. nRollmed
13.3.1. Interview Transcript: Hagit Nof, Chief Operation Officer and Business Development Officer
13.4. Seeker Health
13.4.1. Interview Transcript: Paul Ivsin, Managing Director

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS


List of Tables
Table 3.1 Salient Features of Clinical Trial Phases
Table 4.1 Traditional and Emerging Patient Outreach Methods
Table 5.1 List of Patient Recruitment and Retention Service Providers
Table 5.2 Patient Recruitment and Retention Service Providers: Information on Patient Outreach Methods
Table 5.3 Patient Recruitment and Retention Service Providers: Information on Type of Patient Recruitment Services
Table 5.4 Patient Recruitment and Retention Service Providers: Information on Patient Retention Methods
Table 5.5 Patient Recruitment and Retention Service Providers: Information on Geographical Reach
Table 5.6 Patient Recruitment and Retention Service Providers: Information on Therapeutic Expertise
Table 5.7 Patient Recruitment and Retention Service Providers: Information on Payment Model, Recruitment Technology / Platform, and Regulatory Approval / Certification / Compliance Status
Table 7.1 Acurian: Funding
Table 7.2 Acurian: Future Outlook
Table 7.3 BBK Worldwide: Future Outlook
Table 7.4 ClinEdge: Future Outlook
Table 7.5 CSSi: Future Outlook
Table 7.6 WCCT Global: Future Outlook
Table 7.7 Antidote: Funding
Table 7.8 Antidote: Future Outlook
Table 7.9 FIDELIS RESEARCH: Future Outlook
Table 7.10 Ignite Data: Future Outlook
Table 7.11 Raremark: Future Outlook
Table 7.12 CROèe: Future Outlook
Table 7.13 Pacific Grove: Future Outlook
Table 8.1 Patient Recruitment and Retention Services: Partnerships and Collaborations, 2013-2018

Table 14.1 Patient Recruitment and Retention Service Providers: Distribution by Year of Establishment
Table 14.2 Patient Recruitment and Retention Service Providers: Distribution by Company Size
Table 14.3 Patient Recruitment and Retention Service Providers: Distribution by Geography
Table 14.4 Patient Recruitment and Retention Service Providers: Distribution by Type of Services Offered
Table 14.5 Patient Recruitment and Retention Service Providers: Distribution by Type of Patient Outreach Methods
Table 14.6 Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Outreach Methods Offered
Table 14.7 Patient Recruitment and Retention Service Providers: Distribution by Patient Recruitment Associated Services
Table 14.8 Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Recruitment Associated Services Offered
Table 14.9 Patient Recruitment and Retention Service Providers: Distribution by Patient Retention Methods
Table 14.10 Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Retention Methods
Table 14.11 Patient Recruitment and Retention Service Providers: Distribution by Geographical Reach
Table 14.12 Patient Recruitment and Retention Service Providers: Distribution by Therapeutic Expertise
Table 14.13 Company Competitiveness Analysis: Small-Sized Players
Table 14.14 Company Competitiveness Analysis: Mid-Sized Players
Table 14.15 Company Competitiveness Analysis: Large Players
Table 14.16 Partnerships and Collaborations: Cumulative Trend by Year, 2013-2018
Table 14.17 Partnerships and Collaborations: Distribution by Type of Partnership
Table 14.18 Partnerships and Collaborations: Distribution by Purpose of Agreement
Table 14.19 Partnerships and Collaborations: Analysis by Therapeutic Area
Table 14.20 Partnerships and Collaborations: Most Active Players
Table 14.21 Overall Patient Recruitment Services Market, Conservative, Base and Optimistic Forecast Scenarios, 2019-2030 (USD Billion)
Table 14.22 Patient Recruitment Services Market: Distribution by Therapeutic Area, 2019 and 2030 (%)
Table 14.23 Patient Recruitment Services Market: Distribution by Steps in Patient Recruitment Process, 2019-2030 (USD Billion)
Table 14.24 Patient Recruitment Services Market: Distribution by Phases of Development, 2019-2030 (USD Billion)
Table 14.25 Patient Recruitment Services Market: Distribution by Geography, 2019-2030 (USD Billion)
Table 14.26 Patient Recruitment Services Market: Market Attractiveness Analysis by Country
Table 14.27 Patient Recruitment Services Market in North America, 2019-2030, Conservative Scenario (USD Billion)
Table 14.28 Patient Recruitment Services Market in North America, 2019-2030, Base Scenario (USD Billion)
Table 14.29 Patient Recruitment Services Market in North America, 2019-2030, Optimistic Scenario (USD Billion)
Table 14.30 Patient Recruitment Services Market in the US: Distribution by Phases of Development, 2019-2030, Conservative Scenario (USD Million)
Table 14.31 Patient Recruitment Services Market in the US: Distribution by Phases of Development, 2019-2030, Base Scenario (USD Million)
Table 14.32 Patient Recruitment Services Market in the US: Distribution by Phases of Development, 2019-2030, Optimistic Scenario (USD Million)
Table 14.33 Patient Recruitment Services Market in the US: Distribution by Therapeutic Areas, 2019-2030, Conservative Scenario (USD Million)
Table 14.34 Patient Recruitment Services Market in the US: Distribution by Therapeutic Areas, 2019-2030, Base Scenario (USD Million)
Table 14.35 Patient Recruitment Services Market in the US: Distribution by Therapeutic Areas, 2019-2030, Optimistic Scenario (USD Million)
Table 14.36 Patient Recruitment Services Market in Canada: Distribution by Phases of Development, 2019-2030, Conservative Scenario (USD Million)
Table 14.37 Patient Recruitment Services Market in Canada: Distribution by Phases of Development, 2019-2030, Base Scenario (USD Million)
Table 14.38 Patient Recruitment Services Market in Canada: Distribution by Phases of Development, 2019-2030, Optimistic Scenario (USD Million)
Table 14.39 Patient Recruitment Services Market in Canada: Distribution by Therapeutic Areas, 2019-2030, Conservative Scenario (USD Million)
Table 14.40 Patient Recruitment Services Market in Canada: Distribution by Therapeutic Areas, 2019-2030, Base Scenario (USD Million)
Table 14.41 Patient Recruitment Services Market in Canada: Distribution by Therapeutic Areas, 2019-2030, Optimistic Scenario (USD Million)
Table 14.42 Patient Recruitment Services Market in EU5, 2019-2030, Conservative Scenario (USD Billion)
Table 14.43 Patient Recruitment Services Market in EU5, 2019-2030, Base Scenario (USD Billion)
Table 14.44 Patient Recruitment Services Market in EU5, 2019-2030, Optimistic Scenario (USD Billion)
Table 14.45 Patient Recruitment Services Market in Germany: Distribution by Phases of Development, 2019-2030, Conservative Scenario (USD Million)
Table 14.46 Patient Recruitment Services Market in Germany: Distribution by Phases of Development, 2019-2030, Base Scenario (USD Million)
Table 14.47 Patient Recruitment Services Market in Germany: Distribution by Phases of Development, 2019-2030, Optimistic Scenario (USD Million)
Table 14.48 Patient Recruitment Services Market in Germany: Distribution by Therapeutic Areas, 2019-2030, Conservative Scenario (USD Million)
Table 14.49 Patient Recruitment Services Market in Germany: Distribution by Therapeutic Areas, 2019-2030, Base Scenario (USD Million)
Table 14.50 Patient Recruitment Services Market in Germany: Distribution by Therapeutic Areas, 2019-2030, Optimistic Scenario (USD Million)
Table 14.51 Patient Recruitment Services Market in France: Distribution by Phases of Development, 2019-2030, Conservative Scenario (USD Million)
Table 14.52 Patient Recruitment Services Market in France: Distribution by Phases of Development, 2019-2030, Base Scenario (USD Million)
Table 14.53 Patient Recruitment Services Market in France: Distribution by Phases of Development, 2019-2030, Optimistic Scenario (USD Million)
Table 14.54 Patient Recruitment Services Market in France: Distribution by Therapeutic Areas, 2019-2030, Conservative Scenario (USD Million)
Table 14.55 Patient Recruitment Services Market in France: Distribution by Therapeutic Areas, 2019-2030, Base Scenario (USD Million)
Table 14.56 Patient Recruitment Services Market in France: Distribution by Therapeutic Areas, 2019-2030, Optimistic Scenario (USD Million)
Table 14.57 Patient Recruitment Services Market in the UK: Distribution by Phases of Development, 2019-2030, Conservative Scenario (USD Million)
Table 14.58 Patient Recruitment Services Market in the UK: Distribution by Phases of Development, 2019-2030, Base Scenario (USD Million)
Table 14.59 Patient Recruitment Services Market in the UK: Distribution by Phases of Development, 2019-2030, Optimistic Scenario (USD Million)
Table 14.60 Patient Recruitment Services Market in the UK: Distribution by Therapeutic Areas, 2019-2030, Conservative Scenario (USD Million)
Table 14.61 Patient Recruitment Services Market in the UK: Distribution by Therapeutic Areas, 2019-2030, Base Scenario (USD Million)
Table 14.62 Patient Recruitment Services Market in the UK: Distribution by Therapeutic Areas, 2019-2030, Optimistic Scenario (USD Million)
Table 14.63 Patient Recruitment Services Market in Italy: Distribution by Phases of Development, 2019-2030, Conservative Scenario (USD Million)
Table 14.64 Patient Recruitment Services Market in Italy: Distribution by Phases of Development, 2019-2030, Base Scenario (USD Million)
Table 14.65 Patient Recruitment Services Market in Italy: Distribution by Phases of Development, 2019-2030, Optimistic Scenario (USD Million)
Table 14.66 Patient Recruitment Services Market in Italy: Distribution by Therapeutic Areas, 2019-2030, Conservative Scenario (USD Million)
Table 14.67 Patient Recruitment Services Market in Italy: Distribution by Therapeutic Areas, 2019-2030, Base Scenario (USD Million)
Table 14.68 Patient Recruitment Services Market in Italy: Distribution by Therapeutic Areas, 2019-2030, Optimistic Scenario (USD Million)
Table 14.69 Patient Recruitment Services Market in Spain: Distribution by Phases of Development, 2019-2030, Conservative Scenario (USD Million)
Table 14.70 Patient Recruitment Services Market in Spain: Distribution by Phases of Development, 2019-2030, Base Scenario (USD Million)
Table 14.71 Patient Recruitment Services Market in Spain: Distribution by Phases of Development, 2019-2030, Optimistic Scenario (USD Million)
Table 14.72 Patient Recruitment Services Market in Spain: Distribution by Therapeutic Areas, 2019-2030, Conservative Scenario (USD Million)
Table 14.73 Patient Recruitment Services Market in Spain: Distribution by Therapeutic Areas, 2019-2030, Base Scenario (USD Million)
Table 14.74 Patient Recruitment Services Market in Spain: Distribution by Therapeutic Areas, 2019-2030, Optimistic Scenario (USD Million)
Table 14.75 Patient Recruitment Services Market in Asia Pacific, 2019-2030, Conservative Scenario (USD Billion)
Table 14.76 Patient Recruitment Services Market in Asia Pacific, 2019-2030, Base Scenario (USD Billion)
Table 14.77 Patient Recruitment Services Market in Asia Pacific, 2019-2030, Optimistic Scenario (USD Billion)
Table 14.78 Patient Recruitment Services Market in Japan: Distribution by Phases of Development, 2019-2030, Conservative Scenario (USD Million)
Table 14.79 Patient Recruitment Services Market in Japan: Distribution by Phases of Development, 2019-2030, Base Scenario (USD Million)
Table 14.80 Patient Recruitment Services Market in Japan: Distribution by Phases of Development, 2019-2030, Optimistic Scenario (USD Million)
Table 14.81 Patient Recruitment Services Market in Japan: Distribution by Therapeutic Areas, 2019-2030, Conservative Scenario (USD Million)
Table 14.82 Patient Recruitment Services Market in Japan: Distribution by Therapeutic Areas, 2019-2030, Base Scenario (USD Million)
Table 14.83 Patient Recruitment Services Market in Japan: Distribution by Therapeutic Areas, 2019-2030, Optimistic Scenario (USD Million)
Table 14.84 Patient Recruitment Services Market in South Korea: Distribution by Phases of Development, 2019-2030, Conservative Scenario (USD Million)
Table 14.85 Patient Recruitment Services Market in South Korea: Distribution by Phases of Development, 2019-2030, Base Scenario (USD Million)
Table 14.86 Patient Recruitment Services Market in South Korea: Distribution by Phases of Development, 2019-2030, Optimistic Scenario (USD Million)
Table 14.87 Patient Recruitment Services Market in South Korea: Distribution by Therapeutic Areas, 2019-2030, Conservative Scenario (USD Million)
Table 14.88 Patient Recruitment Services Market in South Korea: Distribution by Therapeutic Areas, 2019-2030, Base Scenario (USD Million)
Table 14.89 Patient Recruitment Services Market in South Korea: Distribution by Therapeutic Areas, 2019-2030, Optimistic Scenario (USD Million)
Table 14.90 Patient Recruitment Services Market in Australia: Distribution by Phases of Development, 2019-2030, Conservative Scenario (USD Million)
Table 14.91 Patient Recruitment Services Market in Australia: Distribution by Phases of Development, 2019-2030, Base Scenario (USD Million)
Table 14.92 Patient Recruitment Services Market in Australia: Distribution by Phases of Development, 2019-2030, Optimistic Scenario (USD Million)
Table 14.93 Patient Recruitment Services Market in Australia: Distribution by Therapeutic Areas, 2019-2030, Conservative Scenario (USD Million)
Table 14.94 Patient Recruitment Services Market in Australia: Distribution by Therapeutic Areas, 2019-2030, Base Scenario (USD Million)
Table 14.95 Patient Recruitment Services Market in Australia: Distribution by Therapeutic Areas, 2019-2030, Optimistic Scenario (USD Million)
Table 14.96 Patient Recruitment Services Market in China: Distribution by Phases of Development, 2019-2030, Conservative Scenario (USD Million)
Table 14.97 Patient Recruitment Services Market in China: Distribution by Phases of Development, 2019-2030, Base Scenario (USD Million)
Table 14.98 Patient Recruitment Services Market in China: Distribution by Phases of Development, 2019-2030, Optimistic Scenario (USD Million)
Table 14.99 Patient Recruitment Services Market in China: Distribution by Therapeutic Areas, 2019-2030, Conservative Scenario (USD Million)
Table 14.100 Patient Recruitment Services Market in China: Distribution by Therapeutic Areas, 2019-2030, Base Scenario (USD Million)
Table 14.101 Patient Recruitment Services Market in China: Distribution by Therapeutic Areas, 2019-2030, Optimistic Scenario (USD Million)
Table 14.102 Patient Recruitment Services Market in India: Distribution by Phases of Development, 2019-2030, Conservative Scenario (USD Million)
Table 14.103 Patient Recruitment Services Market in India: Distribution by Phases of Development, 2019-2030, Base Scenario (USD Million)
Table 14.104 Patient Recruitment Services Market in India: Distribution by Phases of Development, 2019-2030, Optimistic Scenario (USD Million)
Table 14.105 Patient Recruitment Services Market in India: Distribution by Therapeutic Areas, 2019-2030, Conservative Scenario (USD Million)
Table 14.106 Patient Recruitment Services Market in India: Distribution by Therapeutic Areas, 2019-2030, Base Scenario (USD Million)
Table 14.107 Patient Recruitment Services Market in India: Distribution by Therapeutic Areas, 2019-2030, Optimistic Scenario (USD Million)
Table 14.108 Patient Recruitment Services Market in Rest of the World, 2019-2030, Conservative Scenario (USD Billion)
Table 14.109 Patient Recruitment Services Market in Rest of the World, 2019-2030, Base Scenario (USD Billion)
Table 14.110 Patient Recruitment Services Market in Rest of the World, 2019-2030, Optimistic Scenario (USD Billion)
Table 14.111 Patient Recruitment Services Market in Rest of the World: Distribution by Phases of Development, 2019-2030, Conservative Scenario (USD Million)
Table 14.112 Patient Recruitment Services Market in Rest of the World: Distribution by Phases of Development, 2019-2030, Base Scenario (USD Million)
Table 14.113 Patient Recruitment Services Market in Rest of the World: Distribution by Phases of Development, 2019-2030, Optimistic Scenario (USD Million)
Table 14.114 Patient Recruitment Services Market in Rest of the World: Distribution by Therapeutic Areas, 2019-2030, Conservative Scenario (USD Million)
Table 14.115 Patient Recruitment Services Market in Rest of the World: Distribution by Therapeutic Areas, 2019-2030, Base Scenario (USD Million)
Table 14.116 Patient Recruitment Services Market in Rest of the World: Distribution by Therapeutic Areas, 2019-2030, Optimistic Scenario (USD Million)
Table 14.117 Patient Recruitment and Retention Market: 2019 and 2030 (USD Billion)

List of Figures
Figure 3.1 Factors Contributing to Clinical Trial Costs
Figure 3.2 The Patient Recruitment Process
Figure 3.3 Factors Influencing Participation in Clinical Trials
Figure 3.4 Reasons for Patient Dropouts from Clinical Studies
Figure 4.1 Patient Recruitment: Advantages and Limitations of Traditional Media
Figure 4.2 Patient Recruitment: Advantages and Limitations of Social Media
Figure 5.1 Patient Recruitment and Retention Service Providers: Distribution by Year of Establishment
Figure 5.2 Patient Recruitment and Retention Service Providers: Distribution by Company Size
Figure 5.3 Patient Recruitment and Retention Service Providers: Distribution by Geography
Figure 5.4 Patient Recruitment and Retention Service Providers: Distribution by Geography and Company Size
Figure 5.5 Patient Recruitment and Retention Service Providers: Distribution by Type of Services Offered
Figure 5.6 Patient Recruitment and Retention Service Providers: Distribution by Type of Patient Outreach Methods
Figure 5.7 Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Outreach Methods Offered
Figure 5.8 Patient Recruitment and Retention Service Providers: Distribution by Patient Recruitment Associated Services
Figure 5.9 Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Recruitment Associated Services Offered
Figure 5.10 Patient Recruitment and Retention Service Providers: Distribution by Patient Retention Methods
Figure 5.11 Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Retention Methods
Figure 5.12 Patient Recruitment and Retention Service Providers: Distribution by Geographical Reach
Figure 5.13 Patient Recruitment and Retention Service Providers: Distribution by Therapeutic Expertise
Figure 6.1 Company Competitiveness Analysis: Small-Sized Players
Figure 6.2 Company Competitiveness Analysis: Mid-Sized Players
Figure 6.3 Company Competitiveness Analysis: Large Players
Figure 7.1 Acurian: Innovative Tools / Approaches for Recruiting Patients
Figure 7.2 Acurian: Patient Retention Solutions and Strategies
Figure 7.3 BBK Worldwide: Service Portfolio
Figure 7.4 Bright Pharmaceutical Services: Service Portfolio
Figure 7.5 ClinEdge: Service Offerings
Figure 7.6 CSSi: Patient Recruitment and Retention Capabilities
Figure 7.7 CSSi: Study Branding Strategies
Figure 7.8 CTM: Patient Recruitment Process
Figure 7.9 CTM: Outreach Methods Used to Recruit Patients
Figure 7.10 CTM: Technologies Used to Recruit Patients
Figure 7.11 Antidote: Services Portfolio
Figure 7.12 Antidote Base: Patient Recruitment Process
Figure 7.13 FIDELIS RESEARCH: Service Portfolio
Figure 7.14 Ignite Data: Patient Recruitment and Call-Screening Process
Figure 7.15 Ignite Data: Patient Recruitment Strategies
Figure 7.16 Polaris Biopharma Consulting: Core Capabilities
Figure 7.17 Polaris BioPharma Consulting: Service Portfolio
Figure 7.18 Raremark: Service Portfolio
Figure 7.19 Raremark: Local Support Divisions
Figure 7.20 CROèe: Service Portfolio
Figure 7.21 TrialWire: Patient Recruitment Process
Figure 7.22 TrialWire: RapidRecruit Platform
Figure 7.23 Pacific Grove: Business Divisions
Figure 7.24 Pacific Grove: Patient Enrollment Process
Figure 8.1 Partnerships and Collaborations: Distribution by Year, 2013-2018
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Purpose of Agreement
Figure 8.4 Partnerships and Collaborations: Analysis by Therapeutic Area
Figure 8.5 Partnerships and Collaborations: Most Active Players
Figure 8.6 Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
Figure 9.1 Recent Trends in Patient Recruitment and Retention
Figure 10.1 Patient Recruitment Services Market: Future Growth Opportunities
Figure 10.2 Number of Global Clinical Trials Registered by Year, 2000-2018
Figure 10.3 Evolution of Clinical Trial Regulations in the US
Figure 11.1 Overall Patient Recruitment Services Market, 2019-2030 (USD Billion)

Please contact our Customer Support Center to get the complete Table of Contents